Dividend-Paying Company, M&A, IPO, Secondary Sale: The Exit Paths an Angel Can Realistically Hope For

Before you read: This is general educational information and practical orientation, not legal, accounting, tax, or investment advice; it makes no promise of investment returns, fundraising success, or the possibility of an exit. Exit arrangements involve a company's articles of incorporation, shareholder agreements, securities regulation, tax, deal terms, and case-by-case negotiation. The scenarios and questions below are here to help you think, not to serve as universal conclusions; Taiwan's legal and tax treatment applies case by case, so consult a qualified professional before any formal decision.

The most common exit misconception among angels is to equate "exit" directly with "IPO" — as if the company simply grows up, rings the bell, and the stock turns into cash. But for early-stage investing, an IPO (initial public offering — the first time a company's shares trade on a public market) is only one of many possible endings, and the one with the highest bar and the longest timeline. Most angel bets, win or lose, never reach that point at all. Mature exit thinking is not about predicting "will there be an exit," but about laying out every possible source of liquidity first — asking clearly what conditions each path requires, where it gets stuck, and whether you can personally survive the worst case: your money locked up for years, or wiped out entirely. This article exists to walk through those paths one by one.

An exit is not one road — it is several completely different endings

Angel exits run mainly along five paths: M&A, IPO, secondary sale, dividends, and a long hold — and the trigger usually sits outside the investor's control. These paths need to be thought about separately, because their risk, timing, tax, and term-sheet constraints are completely different, and you cannot stretch one return assumption across all of them.

Start with the "success" script everyone defaults to — which is actually two distinct paths: M&A (the company is bought by an acquirer) and IPO (the company lists on a public market). The two often get lumped together as "a successful exit," but the conditions, timing, and way the money is split differ enormously, which is why the comparison table below breaks them into separate rows. Beyond these two success paths, there is a third: when a next-round investor or strategic party comes in, existing shareholders may get a chance to sell some of their old shares — this is a secondary sale (a "secondary" — what changes hands is shares already held by existing shareholders, not newly issued shares from the company), and it lets you recover part of your position before any final exit. The fourth is when the company neither lists nor gets bought but becomes a steadily profitable business, returning money to shareholders slowly through dividends or earnings distributions. The fifth — the one most easily buried under optimism — is when the company is still alive and operating, but there is no clear buyer and no public market to sell into, so the investor simply holds for the long term, and may end up at zero.

Lay these paths side by side and one thing becomes clear: the trigger for an exit is mostly outside your hands. What you can control is negotiating good terms at entry and thinking your assumptions through clearly; which path the company ultimately takes, and when, depends on the market, the buyer's appetite, the company's performance, and the other shareholders — which is precisely why "how much can I get back, and in how many years" is the wrong question from the very start. One correction worth adding: deep-tech cases such as biotech and hardware have a structurally longer timeline — from clinical trials to chip tape-out to becoming acquisition-worthy — and the pool of secondary buyers is thinner. For these, "hold long, exit late" is often the norm rather than a failure, and seven to ten years is usually a starting point, not a finish line.

The table below places all five paths side by side (with the success exit split into M&A and IPO rows) — not to memorize, but to see clearly how far apart each one's "conditions to occur" and "what to probe" really are:

Path	Possible conditions to occur	What an angel should probe
M&A	Product, customers, technology, team, or market position has strategic value to a buyer	Who might buy, why they would, how the deal consideration is calculated, the shareholder-consent threshold
IPO	The company's scale, governance, financials, compliance, and market conditions are all mature	An early company is usually far from listing — do not treat it as the only assumption
Secondary sale	A new investor, existing shareholder, or strategic party is willing to take on old shares	Are there transfer restrictions, does the company hold a consent right, what about price and disclosure
Dividends / profit sharing	The company is steadily profitable, and the board and shareholders resolve to distribute earnings	Growth-stage startups usually reinvest cash into growth and may not pay dividends
Long hold	The company still operates, but there is no clear buyer or public market	Can the investor absorb the uncertainty of time and liquidity

Why "how many years to break even" is the wrong question

"How many years to break even" is the wrong question because early-stage equity has no maturity date — turning it into cash depends on a single event that no one can guarantee will ever happen, so it is fundamentally not a product whose return can be amortized over a number of years. Early-stage equity is neither a fixed-income product nor a public-market stock. A fixed-income product (a term deposit or a bond, say) has an agreed principal and interest and a clear maturity date; a public-market stock can be sold at the market price at any time. Early-stage equity is neither — its value can only be realized through a single "event" (an acquisition, a listing, or an old-share transfer), and whether and when that event happens, no one can promise. So asking "how many years to break even" treats a fundamentally uncertain, illiquid, long-term equity stake as if it were a maturity-dated savings product — which hides the real risk from the start.

A better way to ask is to break the exit into a set of concrete questions you can put to the founder and also use to examine yourself: who is the most likely future buyer of this company, and why would that buyer feel it has to buy? If it were to list, what scale, governance, and financial thresholds would it need to clear first, and how far is it from there now? Could a next-round investor accept this valuation and cap-table structure, or has this round's pricing already blocked the road ahead? Are my shares actually easy to transfer, and do I need the company's or other shareholders' sign-off? And the last one, the one you most need to be honest with yourself about: if there is no exit event for seven to ten years, can I accept this money simply sitting there? The point of these questions is not to compute a precise answer — early-stage investing cannot produce precise answers — but to force you to build your return expectation on "one of several paths coming true," rather than betting on a single script.

The documents and terms to read before you enter

A large part of an exit's possibility is decided the moment you sign your investment documents. You do not go fighting for rights at exit time — you either negotiated the right clauses in at entry, or you did not. Five items are especially worth confirming before you invest, because they directly determine whether you will have any cards to play later.

Share-transfer restrictions are written into the articles of incorporation, the shareholder agreement, or the investment agreement, and they decide whether your old shares can be sold at all, to whom, and whose consent is required — this single item frames the entire possibility of a secondary sale, and many people discover only when they want to sell that they were tied down all along. Information rights decide whether you receive investor updates, financial statements, or notice of material events after investing; without them, you cannot even see whether the company is still worth holding, whether anyone wants to buy, or how the valuation has moved — you are holding shares inside a black box. Liquidation preference (the right of specified shareholders, when the company is sold or wound up, to stand at the front of the line and recover a defined amount first) is written into the preferred-share terms and decides how the money is divided when the company is sold or liquidated, and who gets paid first — the same sale proceeds can leave different shareholders with wildly different outcomes depending on how the preference is designed. It splits further into two variables worth reading closely: one is the size of the preference multiple (recovering, say, one times or several times the invested amount), and the other is "whether, after taking the preference amount, you can also share in the remaining proceeds alongside the common shares" — being able to is called participating, not being able to is called non-participating, and the difference between the two has a large effect on what you finally receive. Anti-dilution clauses (mechanisms that protect early investors' ownership percentage or value from being overly diluted when later capital is raised at a lower price) and other next-round-related terms affect whether your equity value gets heavily compressed when the company raises again. Finally there are tag-along and drag-along rights: a tag-along right lets minority shareholders sell pro rata alongside a major shareholder when that shareholder sells; a drag-along right works the other way — when the majority decides to sell the company, it can "drag" the minority into selling too. In an M&A, these two directly decide whether a minority shareholder is forced to sell along or can protect their own interests. (For the full picture of these clauses, see Which Terms Should an Angel Watch in a Term Sheet?.)

These clauses look like fine print, but they share a common thread: nearly everything you want to do at exit — sell old shares, exit alongside an acquisition, recover money in a liquidation — and how much you can get back, all point back to what you signed at entry. The chips you play at exit are the ones you put in your pocket the moment you invested.

A real lesson in imagining only one assumption

Talking abstractly about "do not bet on a single path" does not land. A de-identified example makes it clearer.

An angel invested in a B2B software company with a clear script in mind at entry: an exit via acquisition by a large enterprise within five years. Three years passed; the company's revenue stabilized, but growth was not especially fast; no strategic buyer in the market made an unsolicited offer; and when the next funding round came, the incoming investors were only willing to subscribe to newly issued company shares and not to take on the old shares he held. The result — the company had not failed, it was even profitable, but not one of the exit paths he had imagined came through.

The point of this example is not that the company failed (it did not), but that this investor prepared, from start to finish, for only one kind of exit. Had he, before investing, laid out the scenarios of M&A, secondary sale, long hold, and even no liquidity at all, and asked of each "what conditions are needed for this to happen," then the situation three years later would not have been a surprise to him but one of the boxes he had already marked as "possible." Falling into the trap described earlier — "mistaking highly uncertain equity for a maturity-dated savings product" — usually happens not because someone is not smart enough, but because they thought of only one path and stopped. As an aside, this also shows why angel investing needs portfolio thinking (not betting on a single deal, but spreading across many and relying on a few winners to carry the overall return) to diversify — any single deal's exit assumption is too fragile to support your overall strategy.

Three misconceptions that will lead you to a wrong decision

There are three especially common misconceptions about exits, and each one can lull you into relaxing the caution you should hold at entry.

The first is "as long as you back a good company, you are guaranteed an exit." In reality, a good company can perfectly well stay unlisted, unacquired, and closed to share transfers for years — it runs beautifully, yet your equity simply cannot be turned into cash. A company performing well and your being able to exit are two different things; the latter carries an extra layer of liquidity and term-sheet gates.

The second is "a dividend-paying company is safer." This misconception deserves special care in Taiwan, because it touches a specific regulatory sequence. For a dividend to happen, the company must be steadily profitable and the board and shareholders must actually resolve to distribute earnings — which inherently conflicts with a high-growth startup's need to reinvest every dollar of cash into growth. More crucially, under Taiwan's Company Act, a company must first offset accumulated losses, then set aside the statutory legal reserve as required, before it is the shareholders' turn to receive any earnings distribution — and most high-growth startups still carry accumulated losses on their books before any exit. Put these two together and the conclusion is this: for an early-stage angel, recovering money through "company dividends" is, in Taiwan practice, relatively uncommon in principle, and treating it as your primary exit imagination is not a sound bet (individual companies' financials and distribution situations vary case by case, so always rely on actual financial statements and professional advice).

The third is "if someone invests in the next round, early shareholders can sell their shares." This confuses two completely different pools of money: the funds most startups raise in a later round go into the company (the company issues new shares for cash and burns it on growth), and that does not mean anyone wants to buy the old shares you hold. Whether a secondary sale is possible depends, all at once, on whether there is a buyer, whether the company consents, and whether the transfer clauses permit it — three conditions, none optional, and none that automatically holds just because "the company raised another round."

The judgment to take away

An angel exit is less an endpoint you can plan than a set of possibilities you should lay out at entry and keep tracking thereafter. When you look at a deal, rather than asking "how many years to break even," write the exit as one honest assumption: if this company succeeds, what is the most likely source of liquidity? Who would pay, and why? Roughly which milestones would it have to clear? And if none of these happens, can I absorb a long hold — or even a write-off? This assumption does not need to predict the future precisely — no one can — its value is that it forces you, from the very start, to refuse to pin your return expectation on a single path, and, at the moment you enter, to actually put into your pocket the terms you should negotiate, the information rights you should retain, and the transfer flexibility you should preserve. The real homework of an exit never begins when things wrap up; it is already underway on the day you decide whether to invest.

Sources

This article is a general, educational synthesis of practical perspectives. Where it touches Taiwan's Company Act order of earnings distribution, preferred shares, or shareholder-agreement clauses, it explains only conceptual principles; different markets, deal terms, and case situations may warrant different judgments and applicable laws, and formal investment and legal or tax decisions should be confirmed with a qualified professional.

Further reading

• Portfolio Thinking
• Which Terms Should an Angel Watch in a Term Sheet?